Beschreibung GHK-Cu (Kupferpeptid GHK-Cu) ist ein natrlich vorkommendes menschliches Plasmatripeptid, das mit dem Alter deutlich abnimmt
Multi-mechanism research designs
Across preclinical studies, Epitalon has shown: Telomerase activation and telomere extension: Via TRAP assays and fibroblast lifespan extension beyond the Hayflick limit Epigenetic remodeling: Reversal of chromatin aging, histone modulation, and gene promoter binding Redox homeostasis: Increased antioxidant enzymes (SOD, NQO1, catalase) and reduced ROS, lipid peroxidation, and DNA damage Circadian restoration: Upregulation of AANAT/pCREB, normalized melatonin and cortisol rhythms, and clock gene modulation in humans Cancer risk reduction: Reduced tumor multiplicity and delayed onset in HER-2/neu and colon cancer models
Mechanism: Semaglutide works primarily through appetite suppression by acting on GLP-1 receptors in the brain and gut
Clinically, BPC-157 and TB-500 are synergistic
The research on BPC-157 paints an interesting picture of what future peptides for injury recovery might look like